Publicaciones (21) Publicaciones de ANA FÁTIMA CHECA ROS

2023

  1. Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation

    Healthcare (Switzerland), Vol. 11, Núm. 1

  2. Exploring the Link between Cardiorenal and Metabolic Diseases

    Healthcare (Switzerland)

  3. Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs

    Nutrients, Vol. 15, Núm. 3

  4. Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial

    Children, Vol. 10, Núm. 7

  5. Role of the Nephrologist in Non-Kidney Solid Organ Transplant (NKSOT)

    Healthcare (Switzerland), Vol. 11, Núm. 12

  6. The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

2022

  1. Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

2021

  1. Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications

    Nutrients, Vol. 13, Núm. 1, pp. 1-32

  2. Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?

    Epilepsy and Behavior, Vol. 124

  3. Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children

    Psychiatry Research, Vol. 303

2020

  1. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology

    Journal of Child and Adolescent Psychopharmacology, Vol. 30, Núm. 3, pp. 177-188

  2. Light-emitting-diode and Grass PS 33 xenon lamp photic stimulators are equivalent in the assessment of photosensitivity: Clinical and research implications

    Epilepsy Research, Vol. 165

2019

  1. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids

    Minerva Pediatrica, Vol. 71, Núm. 3, pp. 313-325

2018

  1. Clinical Considerations Derived From the Administration of Melatonin to Children With Sleep Disorders

    Pediatric Neurology, Vol. 78, pp. 61-69

  2. Prevention of syncytial respiratory virus infection with palivizumab: Descriptive and comparative analysis after 12 years of use

    Minerva Pediatrica, Vol. 70, Núm. 6, pp. 513-518

2017

  1. Analysis of Different Melatonin Secretion Patterns in Children with Sleep Disorders: Melatonin Secretion Patterns in Children

    Journal of Child Neurology, Vol. 32, Núm. 12, pp. 1000-1008

  2. Automedicación, autoprescripción y medicación «por poderes» en pediatría

    Anales de Pediatria, Vol. 86, Núm. 5, pp. 264-269

2016

  1. Treatments and compositions for attention deficit hyperactivity disorder: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 7, pp. 799-814

2013

  1. Tratamiento del cáncer de tiroides

    Revisiones en Cancer, Vol. 27, Núm. 2, pp. 70-85

2012

  1. Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab

    Case Reports in Oncology, Vol. 5, Núm. 3, pp. 676-681